Celldex Therapeutics, Inc. Gain (Loss) on Disposition of Other Assets
Celldex Therapeutics, Inc. (CLDX) reported Gain (Loss) on Disposition of Other Assets of $500.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2017-08-08
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for the quarter ending 2017-06-30 was $0.00.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for the quarter ending 2017-03-31 was $500.00K, a 16.67% decline year-over-year.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for the quarter ending 2016-12-31 was $2.20M, a 450.00% increase year-over-year.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for the quarter ending 2016-09-30 was $0.00.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for fiscal 2016 was $2.80M, a 180.00% increase from fiscal 2015.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for fiscal 2015 was $1.00M, a 150.00% increase from fiscal 2014.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for fiscal 2014 was $400.00K, a 100.00% increase from fiscal 2013.
- Celldex Therapeutics, Inc. gain (loss) on disposition of other assets for fiscal 2013 was $200.00K, a 100.00% increase from fiscal 2012.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $500.00K 10-Q · filed 2017-08-08 | $2.70M derived: sum of 3 quarters · filed 2017-08-08 | $2.70M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | $500.00K 10-Q · filed 2017-05-09 | $2.70M derived: sum of 2 quarters · filed 2017-05-09 | $2.70M derived: sum of 3 quarters · filed 2017-05-09 | $2.70M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.20M derived: sum of 2 quarters · filed 2017-03-14 | $2.20M derived: sum of 3 quarters · filed 2017-08-08 | $2.80M 10-K · filed 2017-03-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-08-08 | $600.00K 10-Q · filed 2016-11-07 | $1.00M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $600.00K 10-Q · filed 2017-08-08 | $1.00M derived: sum of 3 quarters · filed 2017-08-08 | $1.00M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $600.00K 10-Q · filed 2017-05-09 | $1.00M derived: sum of 2 quarters · filed 2017-05-09 | $1.00M derived: sum of 3 quarters · filed 2017-05-09 | $1.00M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $400.00K derived: sum of 2 quarters · filed 2017-03-14 | $400.00K derived: sum of 3 quarters · filed 2017-03-14 | $1.00M 10-K · filed 2017-03-14 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $600.00K 10-Q · filed 2016-11-07 | $600.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $600.00K 10-Q · filed 2016-08-08 | $600.00K derived: sum of 3 quarters · filed 2017-03-14 | $600.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $600.00K 10-Q · filed 2016-05-05 | $600.00K derived: sum of 2 quarters · filed 2017-03-14 | $600.00K derived: sum of 3 quarters · filed 2017-03-14 | $600.00K derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $0.00 derived: sum of 2 quarters · filed 2017-03-14 | $0.00 derived: sum of 3 quarters · filed 2017-03-14 | $400.00K 10-K · filed 2017-03-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $400.00K 10-Q · filed 2015-11-05 | $400.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $400.00K 10-Q · filed 2015-08-10 | $400.00K derived: sum of 3 quarters · filed 2015-08-10 | $400.00K derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $400.00K 10-Q · filed 2015-04-29 | $400.00K derived: sum of 2 quarters · filed 2015-04-29 | $400.00K derived: sum of 3 quarters · filed 2015-04-29 | $400.00K derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $200.00K 10-K · filed 2015-02-24 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 derived: sum of 2 quarters · filed 2014-11-05 | $200.00K 10-Q · filed 2014-11-05 | $200.00K derived: sum of 4 quarters · filed 2014-11-05 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $200.00K 10-Q · filed 2014-08-07 | $200.00K derived: sum of 3 quarters · filed 2014-08-07 | |
| 2013-03-31 | $200.00K 10-Q · filed 2014-05-01 | $200.00K derived: sum of 2 quarters · filed 2014-05-01 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $100.00K 10-K · filed 2014-03-03 | ||
| 2012-09-30 | $100.00K 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |